Bugworks

Bugworks is a clinical-stage biopharmaceutical company founded in 2014 and incubated at C-CAMP in Bangalore, India. The company harnesses the power of science to develop novel, affordable, and accessible therapies against infectious diseases, antimicrobial resistance (AMR), and cancer. Its pipeline focuses on broad-spectrum antibacterial agents targeting multidrug-resistant pathogens — including both Gram-Negative and Gram-Positive infections — as well as next-generation small molecule oncology therapeutics for hypoxic and immunosuppressed solid tumors. The core scientific team brings over 200 combined years of drug discovery experience, and the company has partnered with the Global Antibiotic R&D Partnership (GARDP) to advance its breakthrough assets.